These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2121833)

  • 1. mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis.
    Baird J; Lazarus GS; Belin D; Vassalli JD; Busso N; Gubler P; Jensen PJ
    J Invest Dermatol; 1990 Nov; 95(5):548-52. PubMed ID: 2121833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue plasminogen activator in psoriasis.
    Jensen PJ; Baird J; Belin D; Vassalli JD; Busso N; Gubler P; Lazarus GS
    J Invest Dermatol; 1990 Nov; 95(5 Suppl):13S-14S. PubMed ID: 16788619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activation in bullous pemphigoid immunohistology reveals urokinase type plasminogen activator, its receptor and plasminogen activator inhibitor type-2 in lesional epidermis.
    Schaefer BM; Jaeger C; Drepper E; Kramer MD
    Autoimmunity; 1996; 23(3):155-64. PubMed ID: 8879451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum is a potent stimulator of keratinocyte tissue plasminogen activator expression.
    Chen CS; Jensen PJ
    J Invest Dermatol; 1996 Feb; 106(2):238-42. PubMed ID: 8601722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal plasminogen activator is abnormal in cutaneous lesions.
    Jensen PJ; Baird J; Morioka S; Lessin S; Lazarus GS
    J Invest Dermatol; 1988 Jun; 90(6):777-82. PubMed ID: 3131439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes.
    Schmidt E; Wehr B; Tabengwa EM; Reimer S; Bröcker EB; Zillikens D
    Clin Exp Immunol; 2004 Mar; 135(3):497-504. PubMed ID: 15008985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical study of the distribution of plasminogen and plasminogen activators in bullous pemphigoid.
    Venning VA; Wojnarowska F; Cederholm-Williams S
    Clin Exp Dermatol; 1993 Mar; 18(2):119-23. PubMed ID: 8481985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator system in pemphigus vulgaris.
    Schaefer BM; Jaeger CJ; Kramer MD
    Br J Dermatol; 1996 Nov; 135(5):726-32. PubMed ID: 8977672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 beta upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT).
    Rox JM; Reinartz J; Kramer MD
    Arch Dermatol Res; 1996 Aug; 288(9):554-8. PubMed ID: 8874752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of plasminogen activator enzymes in psoriatic epidermis.
    Spiers EM; Lazarus GS; Lyons-Giordano B
    J Invest Dermatol; 1994 Mar; 102(3):333-8. PubMed ID: 8120416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
    Bator JM; Cohen RL; Chambers DA
    Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC
    J Vasc Surg; 1997 Jan; 25(1):157-64. PubMed ID: 9013920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis.
    Gissler HM; Frank R; Kramer MD
    Br J Dermatol; 1993 Jun; 128(6):612-8. PubMed ID: 7687853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine A inhibits tPA mRNA transcription in A431 cell line.
    Teofoli P; Mancini A; Lotti T
    Skin Pharmacol; 1996; 9(2):137-40. PubMed ID: 8722609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.
    Braungart E; Magdolen V; Degitz K
    J Invest Dermatol; 2001 May; 116(5):778-84. PubMed ID: 11348470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activation in psoriasis.
    Lotti T; Bonan P; Panconesi E
    Acta Derm Venereol Suppl (Stockh); 1989; 146():36-8. PubMed ID: 2514542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor type 2 is expressed in keratinocytes during re-epithelialization of epidermal defects.
    Bechtel MJ; Wysocki NS; Heidtmann A; Stark HJ; Fusenig N; Kramer MD; Schaefer BM
    Br J Dermatol; 1998 Jan; 138(1):22-8. PubMed ID: 9536219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemphigus IgG induces expression of urokinase plasminogen activator receptor on the cell surface of cultured keratinocytes.
    Seishima M; Satoh S; Nojiri M; Osada K; Kitajima Y
    J Invest Dermatol; 1997 Nov; 109(5):650-5. PubMed ID: 9347794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of urokinase-type plasminogen activator in the pathogenesis of pemphigus].
    Nie Z; Liu R; Ye Q
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):771-3. PubMed ID: 9772525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure.
    Kauhanen P; Sirén V; Carpén O; Vaheri A; Lepäntalo M; Lassila R
    Circulation; 1997 Sep; 96(6):1783-9. PubMed ID: 9323062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.